Related Experiment Video
Updated: Oct 23, 2025
07:36
Tumor Transplantation for Assessing the Dynamics of Tumor-Infiltrating CD8+ T Cells in Mice
Published on: June 12, 2021
7.0K
CD27 expression on Treg cells limits immune responses against tumors
Sabine Muth1,2, Annekatrin Klaric3,4, Markus Radsak4,5
1Institute for Immunology, University Medical Center Mainz, Mainz, Germany. sabine.muth@uni-mainz.de.
Journal of Molecular Medicine (Berlin, Germany)
|August 23, 2021
Summary
Regulatory T cells (Tregs) expressing CD27 limit anti-tumor immunity. Ablating Treg CD27 enhances T cell responses and synergizes with PD-1 blockade for cancer immunotherapy.
Area of Science:
- Immunology
- Cancer Biology
- Cellular Immunology
Background:
- Regulatory T cells (Tregs) are crucial for immune homeostasis but also suppress anti-tumor immunity.
- Treg-mediated suppression of dendritic cells (DCs) is a key mechanism in tolerance and cancer progression.
- The CD70/CD27 axis is implicated in T cell regulation and immune responses.
Purpose of the Study:
- To investigate the role of the CD70/CD27 axis in Treg-mediated suppression of anti-tumor immunity.
- To determine if Treg-expressed CD27 is a target for enhancing cancer immunotherapy.
Main Methods:
- Utilized a mixed bone marrow chimeric mouse model for temporal depletion of Tregs.
- Investigated the impact of ablating Treg-expressed CD27 on anti-tumor immunity.
- Assessed the synergy between Treg CD27 ablation and PD-1 checkpoint inhibition.
Main Results:
- Treg-expressed CD27 was found to maintain peripheral tolerance and limit anti-tumor immunity.
- Depletion of Treg CD27 enhanced cytotoxic T lymphocyte (CTL) mediated immunity against solid tumors.
- Ablation of Treg CD27 synergized with PD-1 blockade, improving CTL-mediated tumor control.
Conclusions:
- Treg-expressed CD27 plays a significant role in immune suppression within the tumor microenvironment.
- Targeting Treg CD27 represents a promising strategy for enhancing cancer immunotherapy.
- The combination of Treg CD27 ablation and PD-1 inhibition offers a potent approach for improving anti-tumor responses.
Related Concept Videos
01:24T Cell Types and Functions
1.6K
When T cells with CD4 markers are activated, they give rise to two types of effector cells: helper T cells and regulatory T cells. Meanwhile, T cells with CD8 markers differentiate into effector cytotoxic T cells. The differentiation of CD4 T cells into helper T cell subsets, such as Th1, Th2, and Th17 cells, is dependent on the antigen type, antigen-presenting cell, and regulatory cytokines.
Th1 cells stimulate dendritic cells to express necessary co-stimulatory molecules on their surfaces for...
Th1 cells stimulate dendritic cells to express necessary co-stimulatory molecules on their surfaces for...
1.6K
01:27Tumor Immunotherapy
773
Immunotherapy is a treatment that boosts or manipulates the immune system to fight diseases, including cancer. For instance, by stimulating an immune response through vaccinations against viruses that cause cancers, like hepatitis B virus and human papillomavirus, these diseases can be prevented. Nonetheless, some cancer cells can avoid the immune system due to their rapid mutation and division. The immune response to many cancers involves three phases: elimination, equilibrium, and escape.
773
01:22T Cell Activation and Clonal Selection
11.0K
T cells are integral to our adaptive immune system, recognizing and effectively responding to foreign antigens. T cell activation and clonal selection are pivotal in orchestrating this immune response. This article elucidates these mechanisms, detailing the roles of cluster of differentiation (CD) markers, major histocompatibility complex (MHC) molecules, costimulatory signals, and the process of clonal selection.
Naive T cells that have not yet encountered an antigen express two primary CD...
Naive T cells that have not yet encountered an antigen express two primary CD...
11.0K
01:27Cytotoxic T Cells-mediated Immune Response
5.1K
Cytotoxic T cells are a vital component of the immune system. They have the remarkable ability to identify and target antigens on infected or abnormal cells. These antigens often originate from intracellular pathogens such as viruses or abnormal proteins cancer cells produce.
Immunological surveillance is the ability of immune cells to monitor and eliminate infected cells with intracellular pathogens, neoplastically transformed cells, and cells with non-self antigens. Cytotoxic T cells and NK...
Immunological surveillance is the ability of immune cells to monitor and eliminate infected cells with intracellular pathogens, neoplastically transformed cells, and cells with non-self antigens. Cytotoxic T cells and NK...
5.1K
01:40Cell-mediated Immune Responses
76.6K
Overview
76.6K